Hinge Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Hinge Health, Inc. (HNGE) on March 17, 2026, reporting events occurring on March 16, 2026. The filing discloses the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It is a corporate governance report rather than a financial results filing.
Material Changes
The primary material change is the appointment of Tyler Sloat as a Class I Director, effective March 16, 2026. Mr. Sloat has been appointed as Chair of the Compensation Committee and as a member of the Audit Committee. His term expires at the 2026 annual meeting of stockholders.
Compensation and Governance Details
- Initial Grant: Mr. Sloat received an initial award of Restricted Stock Units (RSUs) valued at $400,000, vesting annually over three years.
- Annual Cash Compensation (Elected as RSUs):
- $40,000 for Board service.
- $15,000 for Chair of the Compensation Committee.
- $10,000 for Audit Committee service.
- Future Awards: An annual RSU award valued at $200,000 will be granted at the annual meeting beginning in 2027, provided he is serving on the Board.
- Vesting Conditions: RSUs vest in full upon a Change in Control, subject to continued service.
Investor Verification Checklist
- Verify the impact of the new director's background (former COO/CFO of Freshworks Inc. and Zuora Inc.) on the company's strategic direction.
- Review the referenced Director Compensation Program (Exhibit 10.4 to the 2025 Form 10-K) for full terms.
- Confirm the date of the 2026 annual meeting of stockholders to determine the exact expiration of Mr. Sloat's initial term.
- Check for any subsequent filings regarding the vesting schedule or changes to the Compensation Committee composition.